Champions Oncology Exhibiting at the 2012 AACR Annual Meeting
Hackensack, NJ – March 13, 2012 Champions Oncology is pleased to announce that it will be presenting five posters on its Champions TumorGraft™ models and Translational and Personalized Oncology Solutions at the 2012 American Association of Cancer Research (AACR) Annual Meeting on March 31 – April 4 in Chicago, IL. Champions will also be exhibiting at the event at Booth #1037.
The posters can be viewed during the following times during the AACR Annual Meeting. For questions, reprints of the posters, or to arrange a meeting during the event, please contact us.
|1367||4/2/2012||8am-12pm||Characterization of spontaneous metastases in Champions TumorGraft™ models|
|5252||4/2/2012||8am-12pm||Utilization of TumorGraft technology for personalized breast cancer treatment|
|4249||4/3/2012||1pm-5pm||Development of Champions TumorGraft™ models in rare cancer types for oncology drug development|
|3755||4/3/2012||8am-12pm||Antitumor activity of CEP-32496, a novel orally active BRAFV600E inhibitor, in a panel of Champions TumorGraft models of melanoma and colorectal cancer with B-Raf V600E mutations|
|1329||4/4/2012||8am-12pm||Personalizing gastrointestinal cancer treatment by the utilization of TumorGraft technology|